MediPal Holdings Corporation

7459.T
Medical Distribution
2026/09/21 Updated
Market Cap: $3.8B (¥595.0B)
Stock Price: $18.51 (¥2,907)
Exchange Rate: 1 USD = ¥156.99

Notice of Request for an Extraordinary General Meeting of Shareholders by Shareholders

We have received a request for the convocation of an extraordinary general meeting of shareholders. Four agenda items are proposed: removal of Director Shuichi Watanabe, partial amendment of the articles of incorporation, a special dividend, and a share buyback. The company is carefully considering its response policy and intends to continue dialogue.

Importance:
Page Updated: September 2, 2026
IR Disclosure Date: September 2, 2026

Key Figures

  • 臨時株主総会招集請求日: 2026年9月2日
  • 議案数: 4件
  • 配当関連議案の内容: 特別配当 122円/株(2026年9月30日基準日)

AI要約

概要

This document is a notice of a request by shareholders to convoke an extraordinary general meeting. The requestor is The Northern Trust Company AVFC Re: Silchester International Investors International Value Equity Trust and related Silchester funds, and the first agenda item is the removal of Director Shuichi Watanabe, the second is a partial amendment to the articles of incorporation, the third is a distribution of surplus (special dividend), and the fourth is a share buyback. The company is carefully considering its response policy and intends to continue dialogue on medium- to long-term corporate value enhancement going forward.

Impact and Future

Whether the extraordinary meeting is held and whether the proposed agenda items are approved could advance shareholder returns policy, maximize shareholder value, and improve capital efficiency. Silchester emphasizes shareholder returns and centralizes requests for improved capital allocation. Depending on the approval of the removal of Mr. Watanabe and the articles of incorporation amendments, the distribution of powers at the board and dividend policy will attract further attention.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

MediPal Holdings Corporation

Company overview · Stock price · Financial data · All IR

View company page →